Literature DB >> 3022518

Compensated 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism.

L Hegedüs, D Veiergang, S Karstrup, J M Hansen.   

Abstract

Thyroid function and thyroid gland volume, ultrasonically determined, were investigated in 27 hyperthyroid patients with solitary autonomous thyroid nodules before and during one year after 131I-treatment. Total thyroid volume decreased gradually from 40.9 +/- 3.5 ml (mean +/- SEM) before treatment to 23.9 +/- 1.8 ml (P less than 0.001) at 3 months after 131I-treatment. No further change was observed. All but two patients received only one dose of 131I, and in spite of a significant decrease also of the non-adenoma side of the gland, none became hypothyroid. We conclude that 131I-therapy has an important place in the treatment of solitary autonomous thyroid nodules since all our patients became euthyroid within 3 months, only 2 of 27 patients needed more than one dose of 131I, no cases of hypothyroidism occurred, and thyroid volume was substantially decreased.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022518     DOI: 10.1530/acta.0.1130226

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Plummer's disease: localized thyroid autonomy.

Authors:  J D Wiener
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

2.  Radioiodine treatment of multinodular non-toxic goitre.

Authors:  B Nygaard; L Hegedüs; M Gervil; H Hjalgrim; P Søe-Jensen; J M Hansen
Journal:  BMJ       Date:  1993-10-02

3.  Percutaneous intranodular ethanol injection: a new treatment for autonomous thyroid adenoma.

Authors:  A Paracchi; C Ferrari; T Livraghi; E Reschini; R M Macchi; M Bergonzi; P Raineri
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

4.  Outcome of radioactive iodine therapy in Toxic Nodular Goiter in Pakistan.

Authors:  Tauseef Ahmad; Adeel Khoja; Naveed Haroon Rashid; Muhammad Areeb Ashfaq
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.